SUSTAINABLE GROWTH ADVISERS LP
Q2 2022 Form 13-F
STAMFORD, CONNECTICUT
CIK 0001290668
· CRD 127447
· SEC-registered investment adviser
Holdings reported by
PERSONAL CFO SOLUTIONS LLC since Q3 2019
Consolidated report · includes
2 managers
since Q2 2019
$14.0M Reported Value Total
SUSTAINABLE GROWTH ADVISERS, LP reports 93 total accounts under management (AUM). There are 93 discretionary accounts valued at $22,898,554,830, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Source: Form ADV filed 2026-03-30
Reported value
$14.0M
Quarter over quarter
-20.6%
Holdings
55
Top-10 concentration
47.0%
Filing Structure
Reports holdings for
- Virtus Investment Advisers Inc · File #028-00085 · since Q3 2019
- Virtus Fund Advisers LLC · File #028-11308 · since Q2 2019
- ALPS ADVISORS INC · File #028-12230 · Q1 2016 – Q2 2026
- RUSSELL FRANK CO · File #028-01190 · Q2 2013 – Q1 2025 · declared by one filing
- VOYA INVESTMENTS LLC · File #028-04547 · Q1 2024 – Q1 2025 · declared by one filing
- JOHN HANCOCK INVESTMENT MANAGEMENT LLC · File #028-19939 · Q3 2024 – Q1 2025 · declared by one filing
Holdings reported by
- PERSONAL CFO SOLUTIONS LLC · since Q3 2019 · declared by one filing
- Russell Investments Group Ltd · Q4 2023 – Q4 2024 · declared by one filing
Key People
Form ADV owners & control persons
Daniel Cole Callaway
CHIEF COMPLIANCE OFFICER
Hrishikesh Gupta
PRINCIPAL & EXECUTIVE COMMITTEE MEMBER
Alexandra Sunah Lee
PRINCIPAL & EXECUTIVE COMMITTEE MEMBER
Filing Navigation
Earlier filings for this manager are not available.
13F Metrics
Loading 13F Metrics
Q2 2022 13F record
Q2 2022 13F filing summary
| Period of report | June 30, 2022 |
|---|---|
| Filed | August 11, 2022 |
| Form | 13F-HR |
| Reported value | $14.0M |
| Positions | 55 |
| Change in reported value | -99.9% |
| New positions | 2 |
| Exited positions | 6 |
| Position turnover | 13.1% |
| Top-10 concentration | 47.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Oct 15, 2026
|
49 | $9.9B |
|
Q2 2026 13F
Filed Aug 10, 2026
|
47 | $10.2B |
|
Q1 2026 13F
Filed May 11, 2026
|
51 | $10.6B |
|
Q4 2025 13F
Filed Feb 10, 2026
|
54 | $14.4B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
59 | $17.1B |
|
Q2 2025 13F
Filed Aug 8, 2025
|
55 | $19.4B |
|
Q1 2025 13F
Filed May 6, 2025
|
56 | $17.9B |
|
Q4 2024 13F
Filed Feb 10, 2025
|
54 | $19.9B |
|
Q3 2024 13F
Filed Nov 5, 2024
|
53 | $23.6B |
|
Q2 2024 13F
Filed Aug 8, 2024
|
52 | $22.7B |
|
Q1 2024 13F
Filed May 7, 2024
|
54 | $23.9B |
|
Q4 2023 13F
Filed Feb 6, 2024
|
52 | $22.0B |
|
Q3 2023 13F
Filed Nov 9, 2023
|
53 | $19.7B |
|
Q2 2023 13F
Filed Aug 8, 2023
|
56 | $21.1B |
|
Q1 2023 13F
Filed May 9, 2023
|
53 | $17.2B |
|
Q4 2022 13F
Filed Jan 30, 2023
|
55 | $15.4B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
52 | $13.4M |
|
Q2 2022 13F
Filed Aug 11, 2022
|
55 | $14.0M |
|
Q1 2022 13F
Filed May 10, 2022
|
59 | $18.1B |
|
Q4 2021 13F
Filed Feb 10, 2022
|
61 | $19.6B |
34 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | AMZN Amazon.com Inc | $835.4K | 5.98% |
| 2 | MSFT Microsoft Corp. | $817.4K | 5.85% |
| 3 | V Visa Inc | $780.9K | 5.59% |
| 4 | DHR Danaher Corp | $657.4K | 4.71% |
| 5 | GOOG Alphabet Inc CL C | $616.8K | 4.42% |
| 6 | INTU Intuit Inc | $602.8K | 4.31% |
| 7 | UNH UnitedHealth Group Inc | $579.4K | 4.15% |
| 8 | YUM Yum Brands | $575.2K | 4.12% |
| 9 | CRM Salesforce Inc | $567.9K | 4.06% |
| 10 | ADSK Autodesk Inc | $533.2K | 3.82% |
| 11 | MSCI MSCI Inc. | $522.7K | 3.74% |
| 12 | FLT FleetCor Technologies Inc | $467.6K | 3.35% |
| 13 | SPGI S&P Global Inc | $432.7K | 3.1% |
| 14 | WDAY Workday Inc Class A | $425.2K | 3.04% |
| 15 | EQIX Equinix Inc | $412.7K | 2.95% |
| 16 | BALL Ball Corp | $362.9K | 2.6% |
| 17 | TMO Thermo Fisher | $340.8K | 2.44% |
| 18 | ISRG Intuitive Surgical Inc | $340.7K | 2.44% |
| 19 | ECL Ecolab Inc | $327.9K | 2.35% |
| 20 | REGN Regeneron Pharmaceuticals | $303.6K | 2.17% |
Values as reported on the Q2 2022 Form 13F. Every position is in the holdings table below.